Peer-influenced content. Sources you trust. No registration required. This is HCN.

MDLinxHow Cognition Changes Before Dementia Hits

Language Processing Deficits: A New Gateway to Understanding Early Alzheimer’s Disease

A recent study by researchers from MIT, Cornell University, and Massachusetts General Hospital has unveiled a distinct deficit in complex language processing among individuals with amnestic Mild Cognitive Impairment (aMCI), a condition known to precede Alzheimer’s disease. This linguistic shortfall, distinct from the memory impairments typically associated with aMCI, offers a new cognitive biomarker that could enhance early detection and intervention strategies in the battle against dementia.

Key Points:

  • Individuals with aMCI, particularly the amnestic subtype, show an increased risk for developing Alzheimer’s disease compared to cognitively healthy older adults.
  • Researchers have identified a specific deficit in complex language processing in people with aMCI, which is independent of their memory challenges.
  • Patients with aMCI have difficulty processing ambiguous sentences where pronouns refer to individuals not explicitly mentioned in the sentences, indicating a breakdown at the syntax-semantics interface.
  • This linguistic impairment provides a potential new cognitive biomarker for early detection of Alzheimer’s disease, crucial for the effectiveness of emerging treatments.
  • The study involved comparing cognitive performance between aMCI patients and control groups of both younger and older cognitively healthy individuals, focusing on sentence processing involving anaphora.
  • Anaphora refers to the linguistic term where a word relates back to another word or phrase in the sentence, essential for understanding sentence structure and meaning.
  • The findings may influence future neuroscience research towards exploring language processing areas in the brain to understand and potentially predict the progression of dementia.
  • The researchers aim to expand the study size to further define disease progression and the predictive value of language impairment for Alzheimer’s disease.

“These results are among the first to deal with complex syntax and really get at the abstract computation that’s involved in processing these linguistic structures.”
– Suzanne Flynn, MIT Linguistics Scholar


More on Biomarkers

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form